Objective: Given the increased pressure from governmental programs to restructure reimbursements to reflect quality metrics achieved by physicians, review of current reimbursement schemes is necessary to ensure sustainability of the physician's performance while maintaining and ultimately improving patient outcomes. This study reviewed the impact of reimbursement incentives on evidence-based care outcomes within a vascular surgical program at an academic tertiary care center.
Reimbursements for medical care have undergone substantial changes in the past couple of decades in response to the relentless upward march of medical expenses in the United States. [1] [2] [3] The payment structure for physician reimbursement in most health care systems has transitioned from fee-for-service models to schemes based on relative value units (RVUs) in an attempt to quantify performance in a more objective manner. This shift in the business of medicine has required many health systems to re-evaluate their fiscal viability and to develop plans to minimize costs while maximizing profitability to ensure that they continue to provide quality medical care to their patients. [1] [2] [3] [4] [5] Not all hospitals are able to sustain viability, with many hospital groups reporting shrinking margins. Large referral centers, especially tertiary care academic medical centers, are especially at risk as they are required to provide the most complex services regardless of the ability of patients to pay for the care they receive. [6] [7] [8] [9] The application of productivity-based compensation in medicine has become more common in the past decade. Incentive-based programs are not ubiquitous in hospital-based medical practice. However, multiple reports have shown favorable outcomes with the institution of such programs. These programs have been shown to correlate with increases in both patients seen and RVU production. Furthermore, these programs have also demonstrated a concomitant decrease in costs, without adverse effects on teaching time or patient satisfaction. Participation in incentive-based programs has also been shown to improve performance on evidence-based quality measures in primary care practices. The direct overall financial contributions as well as the impact of specific intervention categories of a vascular surgery program on an academic tertiary care center have been previously reported 4 and have demonstrated the profitability of such a vascular surgery program even in the face of rising operating costs. 6 To define the impact of revenue-increasing measures on the quality of surgical patient care, 30-day postoperative outcomes after the creation and implementation of a work RVU-based incentivization program were reviewed.
METHODS
The Division of Vascular Surgery at Cooper University Hospital implemented an RVU-based incentivization compensation program for five full-time surgeons starting on January 1, 2014. This significantly changed the structure of reimbursement from a fixed salary-based model of pay with work RVU-based benchmarks to the majority of pay being reliant on work RVU-based performance. In this payment structure, 80% of the surgeon's compensation is derived from personal work RVU generation and 20% of pay is derived from the group's total work RVU generation. To determine the impact of this financial program on patient care, a retrospective review of the vascular surgery subset of our institution's National Surgical Quality Improvement Program (NSQIP) submission for the calendar years 2013 and 2014 was performed. Data for patients with a confirmed 30-day follow-up were included. Institutional Review Board approval was waived for this database study, and no consents were needed as only deidentified data from the NSQIP were used.
The outcomes reviewed included 30-day mortality, 30-day readmission, and unplanned returns to the operating room. The major morbidities reviewed included wound related (superficial incisional skin and soft tissue infection (surgical site infection [SSI]), deep SSI, organ/ space SSI, wound disruption), respiratory related (pneumonia, unplanned intubation, pulmonary embolism, ventilator dependence >48 hours), renal related (progressive renal insufficiency, acute renal failure, urinary tract infection), central nervous system related (cerebrovascular accident), and cardiac related (cardiac arrest requiring cardiopulmonary resuscitation, myocardial infarction). Specific postoperative morbidities reviewed included deep SSI, pneumonia, pulmonary embolism, venous thrombosis requiring therapy, acute renal failure, cerebrovascular accident, and sepsis/septic shock The financial productivity of the Division of Vascular Surgery at this institution during the study period, defined by total gross charges and total work RVU production, was reviewed. Differences in the outcomes between the two study years were analyzed using Pearson c 2 test and Fisher exact test to calculate P values.
RESULTS
A total of 235 vascular surgical cases were reviewed from the NSQIP sample in 2013 and 257 vascular surgical cases in 2014. No statistically significant difference in the outcomes of the core measures studied (mortality, readmission, unplanned return to the operating room) was identified between the two study periods. Overall perioperative mortality for our cases was 3.0% in 2013 and 2.7% in 2014 (P ¼ .87). Thirty-day readmission was 12.3% in 2013 and 12.5% in 2014 (P ¼ .97). In addition, no statistically significant trends of the major morbidities studied were noted during the two study years. However, a trend toward lower respiratory occurrences was noted in 2014 (Table I) . On review of specific postoperative morbidities studied, there was no statistically significant difference in pneumonia, pulmonary embolism, vein thrombosis requiring therapy, acute renal failure, myocardial infarction, cerebrovascular accident, or sepsis/septic shock. However, there was a trend toward lower incidence of pneumonia between the two study years, with 4.3% in 2013 and 1.6% in 2014 (P ¼ .07; Table II) . During the study period, an increase in both total charges and work RVUs generated was realized. Total charges for all full-time physicians increased by 8.2%, whereas total work RVUs increased by 5.7% (Table III) . Total charges and work RVUs by full-time faculty member were also reviewed (Table IV) .
DISCUSSION
Dedicated reviews of physician productivity as a consequence of the structure of compensation packages and the subsequent impact on patient access and satisfaction have been ongoing. In an attempt to contain health care costs, some health care institutions have turned to pay-for-performance measures. Other programs have attempted to improve compensation by introducing productivity-linked incentives. However, interest is gaining in programs that also link patient quality benchmarks to reimbursement and cost containment. 3, 5, 7, 8, [11] [12] [13] Blue Cross Blue Shield of Michigan has implemented a Physician Group Incentive Program, one of the nation's largest fee-for-value initiatives. This program encompasses >3 million beneficiaries in >11,000 physician practices, accounting for >68% of primary care physicians and 49% of specialists in the state. Multiple incentives, both financial and nonfinancial, are structured within the program to target both cost measures and evidence-based patient care, with high performance on quality measures qualifying physicians for additional reimbursement. A recent analysis of the impact of the program on both spending and quality of patient care from 2008 to 2011 was performed. In this analysis, a consistent pattern of reduced spending was realized while simultaneously improving performance on quality measures, and this impact was more significant over time. 3 In comparison to the Physician Group Incentive Program in Michigan, a recent evaluation of the first 4 years of the Blue Cross Blue Shield of Massachusetts Alternative Quality Contract was performed. In this program, providers are paid a risk-adjusted global budget, which is a two-sided contract with shared savings if spending is below budget and shared risk if spending exceeds the budget. An early structure of this program did not link savings or risk to quality benchmarks; however, this was amended in later years with higher quality translating to a larger share of savings. Analysis of the program demonstrated slowed spending growth with a concomitant improvement in outcome quality. 2 However, some challenge the benefits of the application of RVU-based reimbursement schemes. Disciplines that are not procedure based and largely center on management of multiple chronic comorbidities as well as coordination of care between different groups are worried that RVU-based incentivization may not adequately reflect the complexity of care provided. A survey of academic geriatricians expressed concern about the ability to balance challenging patients with lower reimbursement while being limited in clinical output by academic and trainee responsibilities. 7 In addition, studies have shown that significant differences can even exist between surgical subspecialties with respect to their contribution to hospital margins. 9 Regardless of the exact paradigm adopted and enforced as a measure of cumulative clinical impact, it is clear that the business of medicine requires reform to maximize reimbursement without negatively affecting patient care. Most reports vary in discussion of the financial specifics, ranging from discussion of maximizing profitability through increased productivity to decreasing cost measures across a care group, although all agree that financial sustainability is not possible without altering current practices. Many organizations are moving toward ensuring that financial pressures do not supplant the higher goals of medicine by linking payments to quality measures of patient care or academic productivity and teaching. Some champion the idea of further refining the definition of work units to a new metric that is an amalgam of volume, quality, and efficiency. Models of clinical RVUs, based on patient care, education, and research, have been described as a means of quantifying the obligations inherent to academic medicine within the realm of clinical productivity. 5 The aim of this study was to show that it is possible to preserve current patient care standards and outcomes with the adoption of new financial programs within an academic vascular surgical practice.
CONCLUSIONS
In the current era of health care cost containment and bundled reimbursements, much focus is being placed on reducing health care costs while maintaining and ideally improving health care quality. The data presented here have shown that pay-for-performance reimbursement schemes can help maximize profitability without negatively affecting the quality of patient care. Further studies are needed to determine the long-term impact of compensation-based incentivization programs on both financial stability of health care systems and quality of care delivered to patients. 
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